From childhood to adulthood atopic dermatitis is a condition that can have an extremely negative impact on a person's life. Knowing the best way to manage the symptoms can go a long way in improving quality of life issues.
Researchers discovered a clinically translatable gene therapy protocol, which is a gene delivery system that introduced the production of therapeutic clotting proteins in platelets, so that the inhibition of inactivating antibodies is avoided.
Over the past few months, the Food and Drug Administration (FDA) approved several drugs for the control and prevention of bleeding episodes in patients with hemophilia. Other drug classifications granted included Orphan Drug Status and Breakthrough Therapy designation.